+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

S

Actively Recruiting

Researchers are studying vocal biomarkers to better understand and monitor symptoms related to Long COVID, a condition affecting an estimated 10-20% of COVID-19 patients worldwide. This study aims to develop voice-based indicators for common Long COVID symptoms such as fatigue, brain fog, respiratory problems, sleep issues, stress, and anxiety, to support patient care and improve remote health monitoring. The study is observational and focuses on data collected from users of the Long COVID Companion LCC app, developed with patient input to assist those affected. Participants in this study will use the LCC app at their own pace, recording voice samples and completing health questionnaires over a period of up to 36 months. The app includes features for daily symptom monitoring, voice journaling, and generating reports. New standardized voice recordings and symptom questionnaires will be collected regularly, especially during the initial days after enrollment, to track changes over time. Throughout the study, participants voice characteristics and fatigue levels will be assessed from enrollment up to 24 months. Data collected include self-reported symptoms and voice recordings, all completed remotely via the app. The study also evaluates the apps usability and acceptability. Participants health and voice data help researchers develop personalized monitoring tools and understand the progression of Long COVID symptoms.

Age: 18Years +All Genders
1 location
S

Actively Recruiting

Healthy Volunteer

This research aims to understand how the immune system reacts to tick bites, focusing on the development of alpha-Gal syndrome AGS, a delayed allergy to red meat caused by IgE antibodies against the alpha-Gal sugar transmitted by ticks. The study will compare immune responses between individuals who develop these antibodies and those who do not, investigating early immune markers that may predict allergic sensitization. It also seeks to gather important public health data by analyzing ticks for pathogens. Participants will enroll within 48 hours after a tick bite and provide blood samples and questionnaires. They will return for a follow-up visit 4 to 6 weeks later for additional blood collection and questionnaires. A third visit, including allergy tests, is planned 3 months after the tick bite for participants selected based on their antibody levels. The tick removed from the participant will be collected, identified, and tested for pathogens. During the study, participants will undergo immune analysis through blood samples collected at enrollment and follow-up visits, along with questionnaires about their health, tick bite history, and diet. The study will monitor immune signatures linked to allergic sensitization and track tick-borne diseases over time. The total follow-up spans several weeks, with researchers reviewing immune responses up to two years after the last participant enrolls to better understand the development of AGS.

Age: 18Years +All Genders
2 locations